Keyphrases
IL-17RA
100%
Immune Activation
100%
Gene Suppression
100%
Psoriasis
100%
Targeted Gene
100%
Interleukin-17 (IL-17)
60%
Mouse Model
60%
3D Humans
40%
Psoriatic
40%
Preclinical Safety Studies
20%
Systemic Targeted Therapy
20%
Imiquimod
20%
Psoriatic Skin
20%
Human-induced
20%
Spectacular
20%
Topical Application
20%
Topical Therapy
20%
Imiquimod-induced Psoriasis
20%
Imiquimod-induced
20%
Knockdown
20%
Knock
20%
Nanotechnology
20%
Histopathological Features
20%
Gene Targeting
20%
Spherical nucleic Acids
20%
Epidermal Differentiation
20%
Gel Formulation
20%
Inflammatory Activity
20%
Cytokine Expression
20%
Nanoconjugates
20%
Human Subject Test
20%
Antagonism
20%
Oligonucleotides
20%
Clinical Features
20%
Psoriasis Pathogenesis
20%
Highly Effective
20%
Transcriptomics
20%
Medicine and Dentistry
Psoriasis
100%
Gene Repression
100%
Tumor Necrosis Factor
57%
Imiquimod
28%
Imiquimod-Induced Psoriasis
14%
Targeted Therapy
14%
Nanoconjugate
14%
Transcriptomics
14%
Topical Drug Administration
14%
Cytokine
14%
Systemic Therapy
14%
Nucleic Acid
14%
Receptor
14%
Topical Treatment
14%
Oligonucleotide
14%
Diseases
14%
Pharmacology, Toxicology and Pharmaceutical Science
Psoriasis
100%
Tumor Necrosis Factor
57%
Mouse Model
42%
Imiquimod
28%
Receptor
14%
Nucleic Acid
14%
Imiquimod-Induced Psoriasis
14%
Cytokine
14%
Nanoconjugate
14%
Oligonucleotide
14%
Diseases
14%